PCPCThe McGill node has received funding from the Genome Canada Genomic Applications Partnership Program (GAPP) to develop PD-L1 Mass Spectrometry (MS)-based assays for use in immune-oncology.
CPTAC and researchers from the University of Victoria – Genome British Columbia Proteomics Centre just released over 130 quantitative, fit-for-purpose, multiplexed mouse multiple reaction monitoring (
In partnership with Agilent, we have upgraded 2 of our 6490 triple quadrupole mass spectrometers the the latest 6495b platforms. These newer instruments enable greater sensitivity and the ability to q
Members of the PCPC have 13 posters and 5 oral presentations at ASMS 2019! See you there!!! #ASMS2019